These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 3825169)

  • 1. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology and physiology of microcirculation.
    Schmid-Schönbein H
    Ric Clin Lab; 1981; 11 Suppl 1():13-33. PubMed ID: 7188106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheology and coronary heart disease].
    Leschke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorrheological changes in ischemic heart disease].
    Forconi S; Guerrini M; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Di Perri T
    Ric Clin Lab; 1983; 13 Suppl 3():195-208. PubMed ID: 6672996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in blood filterability in cerebrovascular accidents.
    Boisseau MR; Freyburger G; Lorient-Roudaut MF
    Wien Med Wochenschr; 1986; 136 Spec No():44-6. PubMed ID: 3825170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of blood viscosity and erythrocyte filterability in chronic ischemic heart disease].
    Strano A; Avellone G; Novo S; Davì G; Di Garbo V
    Ric Clin Lab; 1985; 15 Suppl 1():179-84. PubMed ID: 4035213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte aggregation in clinical medicine.
    Ehrly AM
    Klin Wochenschr; 1986 Oct; 64(20):1081-4. PubMed ID: 3784459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes.
    Pfafferott C; Moessmer G; Ehrly AM; Bauersachs RM
    Clin Hemorheol Microcirc; 1999; 21(1):35-43. PubMed ID: 10517486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of therapeutic plasmapheresis on rheological properties of blood in patients with ischemic heart disease].
    Zadionchenko VS; Bezprozvannyĭ AB; Dzhanashiia PKh; Romashkin AV; Kuznetsova EIu; Borzova LV; Dobashina AN
    Sov Med; 1991; (10):3-6. PubMed ID: 1801230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodilution].
    Landgraf H
    Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemorheologic findings in patients with ischemic heart disease].
    Kunsch R; Bull K; Moufti M; Richter T; Schäbitz J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(5):803-5. PubMed ID: 2481631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
    Wiek J; Krause M; Wiederholt M; Hansen LL
    Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow characteristics of blood and its therapeutic modification].
    Reinhart WH
    Schweiz Med Wochenschr; 1987 May; 117(18):693-7. PubMed ID: 3589626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isovolemic hemodilution in patients with coronary heart disease].
    Kiesewetter H; Erlenwein S; Jung F; Wenzel E; Vogel W; Dyckmans J; Bach R; Hahmann H; Schieffer H; Bette L
    Klin Wochenschr; 1988; 66 Suppl 15():8-14. PubMed ID: 3184787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.